The study explores the efficacy of three-dose monovalent or bivalent vaccinations in neutralizing newly emerged SARS-CoV-2 variants BA.2.86 and FLip. While BA.2.86 showed lower immune evasion abilities compared to recent XBB variants, it was less effectively neutralized by the monoclonal antibody S309, raising questions about vaccine efficacy against evolving strains.
Masking Policies Show Clear Impact on Hospital-Onset Respiratory Infections
In this exclusive MedPage Today video, Theodore Pak, MD, PhD, of Harvard Medical School in Boston, discusses the findings from a study that examined how
December 11, 2024